Baird Financial Group’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-15,528
Closed -$40.2K – 1963
2026
Q2
$40.2K Buy
+15,528
New +$45.9K ﹤0.01% 1918

Other funds holding AVXL

Baird Financial Group's AVXL Position: Q3 2026 in Review

Baird Financial Group sold out of Anavex Life Sciences (AVXL) in Q3 2026, closing a stake of 15,528 shares — an estimated $40.2K sold.

Baird Financial Group first reported a position in AVXL in Q2 2026 and held it in 1 quarter. The position peaked at $40.2K in Q2 2026. 167 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

  • Baird Financial Group reported no remaining Anavex Life Sciences position as of Q3 2026 after selling out during the quarter.
  • Baird Financial Group sold 15,528 Anavex Life Sciences shares in Q3 2026, an estimated $40.2K.
  • Baird Financial Group first reported a position in Anavex Life Sciences in Q2 2026 and held it in 1 quarter.
  • Baird Financial Group's Anavex Life Sciences position peaked at $40.2K in Q2 2026.
  • 167 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on Baird Financial Group's 13F filing for Q3 2026, filed 13 Nov 2026.